Show simple item record

dc.contributor.authorTomlinson, OW
dc.contributor.authorMarkham, L
dc.contributor.authorWollerton, RL
dc.contributor.authorKnight, BA
dc.contributor.authorDuckworth, A
dc.contributor.authorGibbons, MA
dc.contributor.authorScotton, CJ
dc.contributor.authorWilliams, CA
dc.date.accessioned2022-12-23T16:06:59Z
dc.date.issued2022-12-22
dc.date.updated2022-12-23T15:48:40Z
dc.description.abstractBackground: Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO2peak), are acknowledged as biomarkers in the diagnostic and prognostic management of interstitial lung disease (ILD). However, the validity and repeatability of CPET in those with ILD has yet to be fully characterised, and this study flls this evidence gap. Methods: Twenty-six people with ILD were recruited, and 21 successfully completed three CPETs. Of these, 17 completed two valid CPETs within a 3-month window, and 11 completed two valid CPETs within a 6-month window. Technical standards from the European Respiratory Society established validity, and repeatability was determined using mean change, intraclass correlation coefcient and typical error. Results: Every participant (100%) who successfully exercised to volitional exhaustion produced a maximal, and therefore valid, CPET. Approximately 20% of participants presented with a plateau in VO2, the primary criteria for establishing a maximal efort. The majority of participants otherwise presented with secondary criteria of respiratory exchange ratios in excess of 1.05, and maximal heart rates in excess of their predicted values. Repeatability analyses identifed that the typical error (expressed as percent of coefcient of variation) was 20% over 3-months in those reaching volitional exhaustion. Conclusion: This work has, for the frst time, fully characterised how patients with ILD respond to CPET in terms of primary and secondary verifcation criteria, and generated novel repeatability data that will prove useful in the assessment of disease progression, and future evaluation of therapeutic regimens where VO2peak is used as an outcome measure.en_GB
dc.description.sponsorshipRoyal Devon and Exeter NHS Foundation Trust Hospitalen_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.description.sponsorshipGW4 BioMed Medical Research Councilen_GB
dc.identifier.citationVol. 22, No. 1, article 485en_GB
dc.identifier.doihttps://doi.org/10.1186/s12890-022-02289-0
dc.identifier.urihttp://hdl.handle.net/10871/132080
dc.identifierORCID: 0000-0003-4063-7682 (Tomlinson, Owen W)
dc.language.isoenen_GB
dc.publisherBMCen_GB
dc.rights© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.en_GB
dc.subjectAerobic fitnessen_GB
dc.subjectClinical physiologyen_GB
dc.subjectMaximal exerciseen_GB
dc.subjectPulmonary diseaseen_GB
dc.titleValidity and repeatability of cardiopulmonary exercise testing in interstitial lung diseaseen_GB
dc.typeArticleen_GB
dc.date.available2022-12-23T16:06:59Z
exeter.article-number485
dc.descriptionThis is the final version. Available from BMC via the DOI in this record. en_GB
dc.descriptionAvailability of data and materials: Data cannot be deposited in open access repositories for ethical reasons. Please contact the corresponding author (CAW) to discuss data access.en_GB
dc.identifier.eissn1471-2466
dc.identifier.journalBMC Pulmonary Medicineen_GB
dc.relation.ispartofBMC Pulmonary Medicine, 22(1)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-12-15
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-12-22
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-12-23T15:59:02Z
refterms.versionFCDVoR
refterms.dateFOA2022-12-23T16:07:51Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-12-22


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Except where otherwise noted, this item's licence is described as © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.